Blackstone Inc. business relationships
Companies named in Blackstone Inc.’s 10-K filed 2026-02-27, and public companies whose annual reports name Blackstone Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 7.7 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 40 / 100
- AI adoption
- 0 / 100
Named in Blackstone Inc.’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name Blackstone Inc. 31
“The Company has provided and purchased services to and from various affiliates of certain directors or entities under common control, this includes entities under the common control of CVC and Blackstone.” SEC filing
“Rights to qualifying royalties sold to Blackstone apply to net sales of XDEMVY in the U.S. from April 1,” SEC filing
“Rather, Blackstone is only entitled to receive the qualifying royalties and milestones based on XDEMVY's net sales, as outlined within our license agreement with Tarsus.” SEC filing
“• Announced a strategic collaboration with Amwins Group, Inc. and Blackstone Inc. to form Lloyd's Syndicate 2479, providing capacity for portfolio solutions.” SEC filing
“In April 2020, we sold to BX Bodyguard Royalties L.P. (an affiliate of The Blackstone Group Inc.), or Blackstone Royalties, 50% of the royalties payable to us with respect to net sales by Novartis, its affiliates or sublicensees of Leqvio under the MDCO License Agreement.” SEC filing
“As discussed above, under our agreement with Blackstone Royalties, if the revenues generated by the royalties received by Blackstone Royalties from us with respect to Leqvio sales do not reach a certain level by the end of 2029, Blackstone Royalties will be entitled to a higher royalty percentage be...” SEC filing
“Moreover, any adverse actions by Novartis with respect to, or disputes with Novartis regarding, the MDCO License Agreement could adversely impact our ability to comply with our obligations under our agreements with Blackstone Royalties.” SEC filing
“The Blackstone Group Inc. In April 2020, we entered into a strategic financing collaboration with certain affiliates of Blackstone to accelerate our advancement of RNAi therapeutics.” SEC filing
“The amount of funding ultimately provided by Blackstone Life Sciences for the Phase 3 clinical trial of zilebesiran is dependent on us achieving the remaining specified development milestones.” SEC filing
“We are able to originate attractive assets from both our deeply experienced internal teams as well as from our two major partners, Blackstone and BlackRock.” SEC filing
“PPL owns 51% of the joint venture interest and Blackstone Infrastructure owns 49%.” SEC filing
“On April 3, 2025, we received approximately $77 million of gross proceeds from the contribution of our data centers to our joint venture with Blackstone.” SEC filing
“These markets leverage our existing team's spread-based capabilities as well as our strategic partnership with Blackstone.” SEC filing
“We rely on our investment management advisory agreements ("IMA") with Blackstone ISG-I Advisors LLC ("BIS") and other investment managers and sub-managers for the management of portions of certain of our life insurance companies' investment portfolios.” SEC filing
“During the third quarter of 2025, F&G announced the launch of a strategic partnership with a new reinsurance vehicle backed by Blackstone managed funds, with approximately $1 billion in anticipated capital commitments.” SEC filing
“Consequently, we announced that we were planning to start a confirmatory vaccine efficacy study, P304, funded by project financing through Blackstone Life Sciences, a collaboration we announced in 2024.” SEC filing
“Contingent upon regulatory approval in the U.S. and only if the approval is dependent on data from the funded activities, Blackstone will be entitled to receive low single-digit percentage royalties and up to $ 750 million in sales milestone payments.” SEC filing
“On August 28, 2023, we, together with Hudson Pacific Properties and Blackstone Inc., formed a joint venture to develop Pier 94 into a 266,000 square foot purpose-built studio campus in Manhattan.” SEC filing
“Our 10-year relationship with Blackstone began to wind down just prior to our initial public offering ("IPO"), in 2021 when Blackstone sold a 10% interest in us to our managing partners, helping us to expand the partnership.” SEC filing
“(i) Strategic Collaboration and Financing Agreement, (the "Blackstone Collaboration Agreement");” SEC filing
“In connection with the Blackstone Loan Agreement (see below), Antecip consented to the collateral assignment of one of the license agreements, among other things, under a direct agreement among us, Antecip, a related party, and Blackstone.” SEC filing
“AvenCell Therapeutics, Inc. ("AvenCell") was formed in July 2021 as a joint venture between us, Cellex Cell Professionals GmbH ("Cellex") and funds managed by Blackstone Life Sciences Advisors L.L.C. ("BXLS").” SEC filing
“Refer to Note 9 below for information relating to the Purchase Agreement between the Company and Blackstone, pursuant to which the Company sold to Blackstone its 4 % royalty, or revenue interest, in potential future net sales of Vaxcyte's PCV products, including VAX-24 and VAX-31.” SEC filing
“As of December 31, 2025, Blackstone has not received any royalty payment from Vaxcyte and, therefore, the deferred royalty obligation has not begun to be amortized.” SEC filing
“...ognized over the estimated life of the royalty term arrangement using the effective interest method based on the imputed interest rate derived from estimated amounts and timing of potential future royalty payments to be earned and received by Blackstone from Vaxcyte under the 2015 License Agreement.” SEC filing
“...ant portion of our future revenue and cash resources is expected to be derived from some of these agreements, along with our royalty monetization agreement, or Purchase Agreement, with an affiliate of Blackstone Life Sciences, or Blackstone, or other similar agreements into which we may enter in the” SEC filing
“Amended and Restated Incremental Term Facility Commitment Letter, dated November 10, 2025, by Loar Group Inc. with Blackstone Alternative Credit Advisors LP (on behalf of the funds, accounts and clients managed, advised or sub-advised by it or its affiliates).” SEC filing
“During fiscal year 2025, by mutual agreement two co-development agreements with Blackstone were terminated.” SEC filing
“...ons continue at a mid-to-high single digit royalty percentage of applicable net sales until aggregate royalty payments since commercial launch have reached an amount equal to a low single digit multiple of the aggregate funding (the "Net Sales Threshold") provided by Blackstone under such agreement.” SEC filing
“Studies, a senior advisor for Blackstone Private Equity, and a venture partner for SineWave Ventures, LLC.” SEC filing
“In December 2025, the Company entered into a new investment fund partnership with Blackstone Credit & Insurance ("BXCI") to invest in current and next generation aircraft engines.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.